Alcami, a leading contract development and manufacturing organisation (CDMO), today announced the appointment of biologics ...
Personalised medicine has commercial promise, but delivering it on the packaging line is a significant challenge. At CPHI ...
Revenue and adjusted EBITDA rose significantly in the second quarter of 2026 compared to the first quarter of 2026, but ...
The agreement will see MedPharm support the transfer and commercial manufacture of an undisclosed branded speciality topical ...
C2 Pharma has added brinzolamide to its ophthalmic API portfolio following completion of process validation and submission of ...
Thermo Fisher Scientific, the world leader in serving science, today announced the Gibco™ CHO-K1 Catalog Panel, a cGMP-ready portfolio of basal and feed media designed to support strong cell growth ...
Most pharmaceutical companies have set ambitious decarbonisation targets, with supply-chain-related emissions accounting for ...
Shilpa Biologicals has launched SB HiMax, an integrated CDMO platform designed to take monoclonal antibodies from gene to GMP ...
Former Olink Proteomics president brings life-science tools leadership experience as Dr Michael Chen transitions to chief ...
Alcami, a leading contract development and manufacturing organisation (CDMO), today announced the appointment of biologics ...
Explore the rise of AI in pharmaceutical quality and the risks of over-reliance, examining why experience, instinct and ...
The CDMO's MaruX platform, ShunzymeX purification technology and COO Maja Pedersen are all shortlisted ahead of its CPHI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results